Source author record

Shun Lu

Shun Lu appears in the imported research catalog. Authorship, coauthor and topic links are available while profile ownership is still unclaimed.

ResearcherUnclaimed source record

Catalog footprint

What is connected

3works
7topics
4close collaborators

Actions

Connect this record

Log in to claim

Research graph

See the researcher in context

Open full explorer

Inspect adjacent papers, topics, institutions and collaborators without losing the researcher page.

Building this map preview

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

3 published item(s)

preprint2021arXiv

DARTS-: Robustly Stepping out of Performance Collapse Without Indicators

Despite the fast development of differentiable architecture search (DARTS), it suffers from long-standing performance instability, which extremely limits its application. Existing robustifying methods draw clues from the resulting deteriorated behavior instead of finding out its causing factor. Various indicators such as Hessian eigenvalues are proposed as a signal to stop searching before the performance collapses. However, these indicator-based methods tend to easily reject good architectures if the thresholds are inappropriately set, let alone the searching is intrinsically noisy. In this paper, we undertake a more subtle and direct approach to resolve the collapse. We first demonstrate that skip connections have a clear advantage over other candidate operations, where it can easily recover from a disadvantageous state and become dominant. We conjecture that this privilege is causing degenerated performance. Therefore, we propose to factor out this benefit with an auxiliary skip connection, ensuring a fairer competition for all operations. We call this approach DARTS-. Extensive experiments on various datasets verify that it can substantially improve robustness. Our code is available at https://github.com/Meituan-AutoML/DARTS- .

preprint2021arXiv

SpeechNAS: Towards Better Trade-off between Latency and Accuracy for Large-Scale Speaker Verification

Recently, x-vector has been a successful and popular approach for speaker verification, which employs a time delay neural network (TDNN) and statistics pooling to extract speaker characterizing embedding from variable-length utterances. Improvement upon the x-vector has been an active research area, and enormous neural networks have been elaborately designed based on the x-vector, eg, extended TDNN (E-TDNN), factorized TDNN (F-TDNN), and densely connected TDNN (D-TDNN). In this work, we try to identify the optimal architectures from a TDNN based search space employing neural architecture search (NAS), named SpeechNAS. Leveraging the recent advances in the speaker recognition, such as high-order statistics pooling, multi-branch mechanism, D-TDNN and angular additive margin softmax (AAM) loss with a minimum hyper-spherical energy (MHE), SpeechNAS automatically discovers five network architectures, from SpeechNAS-1 to SpeechNAS-5, of various numbers of parameters and GFLOPs on the large-scale text-independent speaker recognition dataset VoxCeleb1. Our derived best neural network achieves an equal error rate (EER) of 1.02% on the standard test set of VoxCeleb1, which surpasses previous TDNN based state-of-the-art approaches by a large margin. Code and trained weights are in https://github.com/wentaozhu/speechnas.git

preprint2012arXiv

Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire

Idiosyncratic adverse drug reactions are unpredictable, dose independent and potentially life threatening; this makes them a major factor contributing to the cost and uncertainty of drug development. Clinical data suggest that many such reactions involve immune mechanisms, and genetic association studies have identified strong linkage between drug hypersensitivity reactions to several drugs and specific HLA alleles. One of the strongest such genetic associations found has been for the antiviral drug abacavir, which causes severe adverse reactions exclusively in patients expressing the HLA molecular variant B*57:01. Abacavir adverse reactions were recently shown to be driven by drug-specific activation of cytokine-producing, cytotoxic CD8+ T cells that required HLA-B*57:01 molecules for their function. However, the mechanism by which abacavir induces this pathologic T cell response remains unclear. Here we show that abacavir can bind within the F-pocket of the peptide-binding groove of HLA-B*57:01 thereby altering its specificity. This supports a novel explanation for HLA-linked idiosyncratic adverse drug reactions; namely that drugs can alter the repertoire of self-peptides presented to T cells thus causing the equivalent of an alloreactive T cell response. Indeed, we identified specific self-peptides that are presented only in the presence of abacavir, and that were recognized by T cells of hypersensitive patients. The assays we have established can be applied to test additional compounds with suspected HLA linked hypersensitivities in vitro. Where successful, these assays could speed up the discovery and mechanistic understanding of HLA linked hypersensitivities as well as guide the development of safer drugs.